Secondary sideroblastic anemia due to disease
ICD-10 D64.1 is a billable code used to indicate a diagnosis of secondary sideroblastic anemia due to disease.
Secondary sideroblastic anemia is a type of anemia characterized by the presence of ringed sideroblasts in the bone marrow, which are erythroblasts that contain iron granules. This condition arises due to underlying diseases that affect hemoglobin synthesis, leading to ineffective erythropoiesis. Common causes include chronic inflammatory diseases, malignancies, and exposure to certain drugs or toxins. In patients with secondary sideroblastic anemia, the bone marrow fails to produce adequate healthy red blood cells, resulting in symptoms such as fatigue, weakness, pallor, and shortness of breath. The diagnosis is typically confirmed through a combination of blood tests, bone marrow biopsy, and iron studies. Treatment focuses on managing the underlying condition, which may involve the use of medications, blood transfusions, or iron chelation therapy. Understanding the etiology and pathophysiology of this anemia is crucial for effective management and coding.
Detailed lab results, bone marrow biopsy reports, and treatment plans.
Patients presenting with fatigue and pallor, requiring evaluation for anemia.
Ensure that all lab findings and underlying conditions are clearly documented to support the diagnosis.
Oncology treatment history, including chemotherapy regimens and response to treatment.
Patients with malignancies who develop anemia as a complication of their disease or treatment.
Document the relationship between the malignancy and the development of sideroblastic anemia.
Used to evaluate anemia and monitor treatment response.
Document the reason for the CBC and any relevant clinical findings.
Hematologists should ensure that all relevant lab results are included in the patient's record.
Primary sideroblastic anemia is a genetic disorder, while secondary sideroblastic anemia is caused by other diseases or conditions that affect red blood cell production.
